logo

Enter Symbol

Blog Articles for SNTA
Mike Havrilla image
Synta Pharma Proceeds with Clinical Trial
By: Mike Havrilla
Publish Date: Tuesday, March 17, 2009
Stocks(s): BMS, BMY, GSK, INFI, MXM, RHHBY, SNTA, STA
Sector(s): Basic Materials, Medical, Industrial Products

Mike Havrilla image
Research Note on Synta Pharma (SNTA)
By: Mike Havrilla
Publish Date: Friday, March 13, 2009
Stocks(s): BMS, BMY, GSK, RHHBY, SNTA
Sector(s): Medical

Ohad Hammer image
Biotech Portfolio Updates - Rigel Is Still On Track, Pfizer May Have Found Its Next Blockbuster
By: Ohad Hammer
Publish Date: Friday, January 09, 2009
Stocks(s): ARQL, BBI, BMY, EXEL, PFE, RIGL, SNTA
Sector(s): Medical

Mike Havrilla image
A New Index Of Emerging Biotech And Pharma Companies
By: Mike Havrilla
Publish Date: Saturday, November 22, 2008
Stocks(s): BMRN, CVTX, DLSC, DNDN, EBS, OSIR, SNTA
Sector(s): Medical

Ohad Hammer image
When There Is Blood In The Streets - Buy Biotech
By: Ohad Hammer
Publish Date: Friday, October 10, 2008
Stocks(s): AMGN, ARQL, ARRY, BBI, DNA, EXEL, GILD, IMGN
Sector(s): Medical

Ohad Hammer image
Immunogen at ASCO Annual Meeting 2008
By: Ohad Hammer
Publish Date: Tuesday, July 15, 2008
Stocks(s): ASCO, CRGN, DNA, IMGN, SGEN, SNTA, SNY
Sector(s): Medical

Ohad Hammer image
Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
By: Ohad Hammer
Publish Date: Saturday, May 24, 2008
Stocks(s): ADC, ASCO, CLDA, CRGN, DNA, IMGN, MITI, SGEN
Sector(s): Finance, Medical

Ohad Hammer image
Will Synta Break A 30 Year Old Record?
By: Ohad Hammer
Publish Date: Sunday, April 27, 2008
Stocks(s): KOSN, MLNM, ONXX, SNTA
Sector(s): Oils/Energy, Medical

Ohad Hammer image
Will Synta Break A 30 Year Old Record? (Part I)
By: Ohad Hammer
Publish Date: Monday, April 14, 2008
Stocks(s): CEGE, MEDX, PFE, SNTA
Sector(s): Medical

Kirk Report image
Chalk-Full Of Data
By: Kirk Report
Publish Date: Wednesday, December 05, 2007
Stocks(s): ADLR, ADP, CHNR, CHS, CHTR, CMCSA, CMGI, CPSL
Sector(s): Finance, Computer and Technology, Basic Materials

Page 1 of 1
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia